Abstract
In malignant gliomas, the management of symptoms and minimization of side effects assume major importance. Corticosteroids provide transient relief from neurological symptoms. However, treatment with steroids is also commonly associated with considerable side-effects including: hyperglycemia, osteoporosis, myopathy, lymphopenia and others. Sometimes, antiepileptic drugs may contribute to clinical decline of neuro-oncological patients in stable disease not only by neuropsychological impairment but also by metabolic interations. Several studies have demonstrated a high frequency of hyponatremia among patients treated with carbamazepine and particularly with oxacarbamazepine. Venous thromboembolism is a common complication in patients with cancer and it is particularly high in malignant gliomas, occurring in approximately 20–30% of such patients. Prophylactic treatment in patients with glioblastoma is a key topic. The role of prophylaxis has not yet been established with certainty. Overall the data show a clear reduction of venous thromboembolic events in patients treated with intermittent pneumatic compression (IPC). The addition of enoxaparin dose of 6.000 UI, starting in the perioperative period, induces an increase of major bleeding events. In the absence of availability of IPC, the use of enoxaparin 4.000 UI in addition to graduated compression stockings, reduces thromboembolic events without major bleeding events.
Similar content being viewed by others
References
Koehler PJ (1995) Use of corticosteroids in neuro-oncology. Anticancer Drugs 6:19–33
Oyer DS, Ajul Shah A, Bettenhausen S (2006) How to manage steroid diabetes in the patient with cancer. J Support Oncol 4:479–483
Canalis E, Bilezikian JP, Angeli A, Giustina A (2004) Perspectives on glucocorticoid-induced osteoporosis. Bone 34:593–598
Afifi AK, Bergman RA, Harvey JC (1968) Steroid myopathy. Clinical, histologic and cytologic observations. Johns Hopkins Med J 123:158–173
Dekhuijzen PN, Decramer M (1992) Steroid-induced myopathy and its significance to respiratory disease: a known disease rediscovered. Eur Respir 5:997–1003
Lin CH, Lu C, Wang F, Tsai M, Chang W, Tsai N, Lai S, Tseng Y, Chuang Y (2010) Risk factors of oxcarbazepine-induced hyponatremia in patients with epilepsy. Clin Neuropharm 33:293–296
Suchitra A, James B (2000) Hematologic toxicity of sodium valproate. J Pediatr Hematol Oncol 22:62–65
Fernandez A, Brada M, Zabuliene L, Karavitaki N, Wass JAH (2009) Radiation-induced hypopituitarism. Endocr Relat Cancer 16:733–772
Jenkins EO, Schiff D, Mackman N et al (2010) Venous thromboembolism in malignant gliomas. J Thromb Haemost 8:221–227
Conflict of interest
The authors certify that they have no conflict of interest related to the publication of this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Silvani, A., Gaviani, P., Lamperti, E. et al. Metabolic, electrolytes disorders and tromboembolic risk in malignant glioma patients. Neurol Sci 32 (Suppl 2), 229–231 (2011). https://doi.org/10.1007/s10072-011-0793-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-011-0793-z